Literature DB >> 34249637

Aberrant cerebral perfusion pattern in amnestic mild cognitive impairment and Parkinson's disease with mild cognitive impairment: a comparative arterial spin labeling study.

Song'an Shang1, Jingtao Wu1, Yu-Chen Chen2, Hongri Chen1, Hongying Zhang1, Weiqiang Dou3, Peng Wang2, Xin Cao4, Xindao Yin2.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) has been defined as the prodromal stage of Alzheimer's disease and Parkinson's disease (PD) with dementia. We investigated the differences in regional perfusion properties among MCI subtypes and healthy control (HC) subjects by using arterial spin labeling (ASL).
METHODS: Regional normalized CBF (z-CBF) and CBF-connectivity were analyzed from ASL data in 44 amnestic MCI (aMCI) patients, 42 PD-MCI patients, and 50 matched HC participants. The correlations between these significant regions and clinical performance were investigated separately using Spearman correlation analysis. Receiver operating characteristic analysis was generated to determine the differentiating ability of z-CBF values. z-CBF values in disease-related specific regions were extracted for group comparison.
RESULTS: MCI subgroups showed overlapped impaired regions, aMCI group seemed more extensive than the PD-MCI group. PD-MCI patients had reduced z-CBF in the bilateral putamen, left precentral gyrus, left middle cingulate gyrus, and right middle frontal gyrus compared to aMCI group. Correlations to executive performance and motor severity were found in PD-MCI group, and correlations were to memory performance found in aMCI group. CBF-connectivity in left precentral gyrus, left middle cingulate gyrus, and right middle frontal gyrus were significantly altered. All of the significant clusters had good discriminatory ability.
CONCLUSIONS: Normalized CBF as measured by ASL revealed different patterns of perfusion between aMCI and PD-MCI, which were probably linked to distinct neural mechanisms. The present study indicates that z-CBF can provide specific perfusion information for further pathological and neuropsychological studies. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Mild cognitive impairment (MCI); Parkinson’s disease (PD); amnestic; perfusion imaging; regional blood flow

Year:  2021        PMID: 34249637      PMCID: PMC8250029          DOI: 10.21037/qims-20-1259

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  56 in total

Review 1.  Epigenetics in neurodegeneration: a new layer of complexity.

Authors:  Sueli C F Marques; Catarina R Oliveira; Claudia M F Pereira; Tiago F Outeiro
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-22       Impact factor: 5.067

2.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; John F Pearson; Sina Rüeger; Toni L Pitcher; Leslie Livingston; Charlotte Graham; Ross Keenan; Ajit Shankaranarayanan; David C Alsop; John C Dalrymple-Alford; Tim J Anderson
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

3.  Altered resting-state cerebral blood flow and its connectivity in schizophrenia.

Authors:  Jiajia Zhu; Chuanjun Zhuo; Wen Qin; Yongjie Xu; Lixue Xu; Xingyun Liu; Chunshui Yu
Journal:  J Psychiatr Res       Date:  2015-03-14       Impact factor: 4.791

Review 4.  The Network Degeneration Hypothesis: Spread of Neurodegenerative Patterns Along Neuronal Brain Networks.

Authors:  Alexander Drzezga
Journal:  J Nucl Med       Date:  2018-11       Impact factor: 10.057

Review 5.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

Review 6.  Arterial spin labeling: a technical overview.

Authors:  Inger Havsteen; Janus Damm Nybing; Hanne Christensen; Anders F Christensen
Journal:  Acta Radiol       Date:  2018-01-09       Impact factor: 1.990

7.  Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease.

Authors:  Amir Fazlollahi; Fernando Calamante; Xiaoyun Liang; Pierrick Bourgeat; Parnesh Raniga; Vincent Dore; Jurgen Fripp; David Ames; Colin L Masters; Christopher C Rowe; Alan Connelly; Victor L Villemagne; Olivier Salvado
Journal:  J Magn Reson Imaging       Date:  2019-05-30       Impact factor: 4.813

8.  Striato-cortical connections in Parkinson's and Alzheimer's diseases: Relation to cognition.

Authors:  Lubomira Anderkova; Marek Barton; Irena Rektorova
Journal:  Mov Disord       Date:  2017-03-03       Impact factor: 10.338

9.  Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode network.

Authors:  Swati Rane; Manus J Donahue; Daniel O Claassen
Journal:  Alzheimers Dement (Amst)       Date:  2018-09-20

10.  Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson's Disease patients assessed using pseudo-continuous arterial spin labeling.

Authors:  Yufen Chen; Peter Pressman; Tanya Simuni; Todd B Parrish; Darren R Gitelman
Journal:  PeerJ       Date:  2015-11-03       Impact factor: 2.984

View more
  3 in total

1.  White matter damage in patients with mild cognitive impairment in Parkinson's disease.

Authors:  Qian-Qian Li; Ke Wu; Jia-Li Xu; Liang Yin
Journal:  Quant Imaging Med Surg       Date:  2022-02

2.  Evaluating white matter alterations in Parkinson's disease-related parkin S/N167 mutation carriers using tract-based spatial statistics.

Authors:  Jinqiu Yu; Lina Chen; Guoen Cai; Yingqing Wang; Xiaochun Chen; Weimin Hong; Qinyong Ye
Journal:  Quant Imaging Med Surg       Date:  2022-08

3.  Aberrant pattern of regional cerebral blood flow in mild cognitive impairment: A meta-analysis of arterial spin labeling magnetic resonance imaging.

Authors:  Tong Tang; Li Huang; Yusi Zhang; Zuanfang Li; Shengxiang Liang
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.